Skip to navigation Skip to content

Professional Education Calendar

Share

Online CE Opportunities:

  1. Changing Perspectives on the Role of the Immune System in Multiple Sclerosis Pathology, Differentiation, and Targeted Therapies

    In this interactive CME infographic, leading neurologists review current theories and evidence regarding the immunopathogenesis of multiple sclerosis. They assess the mechanisms of action, safety, and efficacy of new therapeutic agents, as well as the latest best practices when using selective high-efficacy agents to treat MS. Chair: Hans-Peter Hartung, MD, FRCP, FAAN, FANA

  2. Cognitive Dysfunction and the Professional Challenges

    webinar

  3. ECTRIMS 2016: Optimally Managing Patients With Multiple Sclerosis Through Individualized Treatment Options

  4. Emerging Oral Therapies in MS

    CME video

  5. Emerging Therapies and Targets for Progressive Multiple Sclerosis

    The past several decades have seen tremendous progress in the treatment of relapsing-remitting multiple sclerosis (MS). In contrast, the treatment of progressive MS remains challenging. Improved understanding of the underlying biology of disease progression has led to the identification of therapeutic targets and potential new treatments.

  6. Expert Debates in Multiple Sclerosis: Opposing Views in Management: Module 1. MRI for Monitoring Disease Progression and Treatment Response in Multiple Sclerosis (MS)

    After completing this activity, the participant should be better able to: • Review and understand the implications of the most current evidence related to the use of MRI in clinical decision making for patients with MS.

  7. Expert Debates in Multiple Sclerosis: Opposing Views in Management: Module 2. Clinically Isolated Syndrome (CIS): Viewpoints on Treatment

    Learning Objectives After completing this activity, the participant should be better able to: • Review and understand the most current evidence related to the decision to choose either established platform therapies or new and emerging agents as first-line therapy in MS

  8. Expert Debates in Multiple Sclerosis: Opposing Views in Management: Module 3. Selection of First-Line Therapy for Relapsing-Remitting Multiple Sclerosis (RRMS): Viewpoints on Established vs Newer Therapies

    Learning Objectives After completing this activity, the participant should be better able to: • Review and understand the most current evidence related to the decision to choose either established platform therapies or new and emerging agents as first-line therapy in MS

  9. Expert Debates in Multiple Sclerosis: Opposing Views in Management: Module 4. Pregnancy-Related Treatment Considerations in Multiple Sclerosis

    Learning Objectives After completing this activity, the participant should be better able to: • Review and understand the most current evidence related to treatment approaches for MS patients who become pregnant or plan to become pregnant

  10. Impact of Pregnancy on MS Disease Activity

    Because multiple sclerosis (MS) predominantly affects women of childbearing age, the issues of conception and pregnancy are of importance to both physicians and patients. This CME/CNE activity reviews the effects of MS on pregnancy and gives clinicians the tools they need to manage MS during the pre-pregnancy, pregnancy, and postpartum periods.

  11. Impact of Pregnancy on MS Disease Activity

    CME activity

  12. Managing Treatment Related Adverse Effects in MS

    All therapies for multiple sclerosis (MS) have potentially negative effects. These include flu-like symptoms with the interferon-betas; injection-site reactions with glatiramer acetate; flushing and gastrointestinal effects with dimethyl fumarate; and diarrhea and hair thinning with teriflunomide. This CME activity will discuss treatment related adverse events in MS and how to treat them.  This activity is supported by an educational grant from Receptos, Inc. Patricia K. Coyle, MD, FAAN, FANA 

  13. Motivational Interviewing to Support Shared Decision Making in MS

    continuing education

  14. MS Highlights from Vancouver: News from the AAN 2016

    three-part CME video

  15. Multiple Sclerosis Outcome Measure Case Study

    online learning.

  16. Multiple Sclerosis: New Options for Care

    Nurse CE course

  17. Multiple Sclerosis: What You Need to Know and the Emotional Challenges

    recorded webinar

  18. New Directions in Multiple Sclerosis: Expert Insights - An Extendable Curriculum

    CME/CNE activity

  19. On-demand CME/CE Wellness Webinar Series

    Webinar

  20. Use of High-efficacy Agents in the Treatment of Relapsing-remitting MS

    First-line treatments often fail to adequately control disease activity in patients with multiple sclerosis (MS). This case-based CME/CNE activity will help clinicians with the process of treatment optimization in patients with MS and with early switching to high-efficacy therapy with breakthrough disease activity. Patricia K. Coyle, MD, FAAN, FANA This activity is supported by educational grants from Genentech, Inc., Genzyme, a Sanofi Company, and Novartis Pharmaceuticals Corporation.

  21. Intro to MS for Fitness and Wellness Professionals

    Free online training course for fitness and wellness professionals, including aquatics instructors, yoga teachers, personal trainers, and others who want to learn more about MS. The course provides an overview of the disease and offers specific strategies for working with a diverse MS population. This online course has been approved by the American Council on Exercise for 0.4 continuing education credits.

In-person CE Opportunities:

PreviousJuly 2016Next
  1. No events found.

Share


Become a Research Champion

An MS Research Revolution

Support MS Research

Understanding and ending MS can’t come fast enough – it will take all of us working together. It’s easy to be a champion for MS Research – join us and proudly let everyone know that you’re helping to lead the MS Research Revolution.

Become a Research Champion

Become a Research Champion